Oncology Institute, Inc. (CIK: 0001799191) EDGAR, Information, Filings... CompaniesBIO.Com

Oncology Institute, Inc.

Mailing address
18000 STUDEBAKER RD, SUITE 800, CERRITOS, Delaware, 90703
Phone
562-735-3226
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8011 - (CF Office: Office of Life Sciences) SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Filings
N/A

Oncology Institute, Inc. (CIK: 0001799191) is an American company incorporated in the state of California. Head office is located at 18000 STUDEBAKER RD, SUITE 800, CERRITOS, California, 90703. Work in the industry 8011 - (CF Office: Office of Life Sciences) SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE. Oncology Institute, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

DFP HEALTHCARE ACQUISITIONS CORP. from 2020-14-Jan to 2021-12-Nov

Owner	Filings	Transaction Date	Type of Owner
Castle Jeremy	0001992507	Sep-05-2023	officer: Chief Operating Officer
Pacala Mark L	0001321250	Sep-21-2022	director
Ling Gabriel	0001945281	Sep-21-2022	director
Shah Mihir	0001676960	Apr-04-2022	officer: Chief Financial Officer, other: Principal Financial Officer
Simoneit Diona	0001921432	Apr-01-2022	officer: Chief Accounting Officer, other: Principal Accounting Officer
Miller Matthew P	0001915822	Mar-15-2022	officer: Chief Operating Officer
SARIN RAVI YANG	0001555959	Nov-12-2021	director
Havencrest Healthcare Partners, L.P.	0001705748	Nov-12-2021	10 percent owner
M33 Growth I L.P.	0001718621	Nov-12-2021	10 percent owner
O'Meara Maeve	0001742487	Nov-12-2021	director
OncologyCare Partners, LLC	0001752450	Nov-12-2021	director
McGeorge Anne	0001779934	Nov-12-2021	director
Dalgleish Scott	0001891053	Nov-12-2021	officer: Chief Financial Officer
Podnos Yale	0001891104	Nov-12-2021	officer: Chief Medical Officer
Virnich Daniel	0001891107	Nov-12-2021	officer: Chief Operating Officer
Hively Brad	0001891124	Nov-12-2021	director, officer: Chief Executive Officer
TOI HC I, LLC	0001892154	Nov-12-2021	10 percent owner
Jimmy Holdings, Inc.	0001892174	Nov-12-2021	10 percent owner
Johnson Karen Marie	0001892819	Nov-12-2021	director
TOI M, LLC	0001892968	Nov-12-2021	10 percent owner
Havencrest Healthcare Partners GP, LLC	0001893722	Nov-12-2021	10 percent owner
M33 Growth I GP LLC	0001894303	Nov-12-2021	10 percent owner
Agajanian Richy	0001895577	Nov-12-2021	10 percent owner
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	0001009258	Mar-10-2020	director, 10 percent owner, other: *Director by Deputization
Deerfield Mgmt L.P.	0001010823	Mar-10-2020	director, 10 percent owner, other: *Director by Deputization
HOCHBERG STEVEN	0001034123	Mar-10-2020	director, 10 percent owner, officer: President and CEO
BARASCH RICHARD A	0001076341	Mar-10-2020	director, officer: Executive Chairman
DEERFIELD PARTNERS, L.P.	0001301041	Mar-10-2020	director, 10 percent owner, other: *Director by Deputization
Flynn James E	0001352546	Mar-10-2020	director, 10 percent owner, other: *Director by Deputization
Wolfe Chris	0001472624	Mar-10-2020	officer: Chief Financial Officer
Atinsky Lawrence	0001674477	Mar-10-2020	director, 10 percent owner, Director by Deputization
Deerfield Private Design Fund IV, L.P.	0001680307	Mar-10-2020	director, 10 percent owner, other: *Director by Deputization
Kaushal Mohit	0001683021	Mar-10-2020	director
Deerfield Mgmt IV, L.P.	0001713467	Mar-10-2020	director, 10 percent owner, other: *Director by Deputization
Sorensen Gregory	0001731883	Mar-10-2020	director
DFP Sponsor LLC	0001806360	Mar-10-2020	director, 10 percent owner, Director by Deputization
Carter Jennifer L.	0001806505	Mar-10-2020	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Oncology Institute, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-24-203246 (34 Act) Size: KB	Aug-20-2024	005-91458 241222840
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-098843 ( Act) Size: 0 KB	Aug-20-2024
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001799191-24-000022 (34 Act) Size: KB	Aug-13-2024	001-39248 241201736
8-K	Document	Current report filing Acc-no: 0001799191-24-000020 (34 Act) Size: KB	Aug-13-2024	001-39248 241201378
8-K	Document	Current report filing Acc-no: 0001079973-24-000949 (34 Act) Size: KB	Jun-21-2024	001-39248 241060841
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001799191-24-000015 ( Act) Size: 0 KB	Jun-20-2024
8-K	Document	Current report filing Acc-no: 0001079973-24-000876 (34 Act) Size: KB	Jun-13-2024	001-39248 241042093
UPLOAD	Document	Acc-no: 0000000000-24-006315 ( Act) Size: KB	Jun-03-2024	001-39248
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001799191-24-000013 ( Act) Size: 0 KB	May-23-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001799191-24-000011 ( Act) Size: 0 KB	May-23-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001799191-24-000010 ( Act) Size: 0 KB	May-23-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001799191-24-000009 ( Act) Size: 0 KB	May-23-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001799191-24-000008 ( Act) Size: 0 KB	May-23-2024
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001553350-24-000041 ( Act) Size: KB	May-22-2024
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001553350-24-000040 (34 Act) Size: KB	May-22-2024	001-39248 24973322
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001553350-24-000039 (34 Act) Size: KB	May-22-2024	001-39248 24973232
UPLOAD	Document	Acc-no: 0000000000-24-005599 ( Act) Size: KB	May-15-2024	001-39248
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001628280-24-023223 (34 Act) Size: KB	May-14-2024	001-39248 24944666
8-K	Document	Current report filing Acc-no: 0001628280-24-023189 (34 Act) Size: KB	May-14-2024	001-39248 24944157
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0001193125-24-129461 (34 Act) Size: KB	May-02-2024	001-39248 24909429

Recent 20 filings. View all Oncology Institute, Inc. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Oncology Institute, Inc. overview
Oncology Institute, Inc. job
Oncology Institute, Inc. stock
Oncology Institute, Inc. ownership
Oncology Institute, Inc. CEO
Oncology Institute, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.